Рет қаралды 1,826
The Food and Drug Administration approved Eli Lilly's Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer's. Neurologist Dr. Tom Pitts details how the medication will clear protein build up in the brain through one's immune system. Pitts also discusses the cost that may be associated with the drug for people using it for 72 weeks.
#FDA #Alzheimers #memoryloss
Get a fast-paced look at the latest from the border to Main Street to the White House on "NewsNation Live with Marni Hughes." Weekdays starting at 10a/9C.#NewsNationLive
NewsNation is your source for fact-based, unbiased news for all America.
More from NewsNation: www.newsnationnow.com/
Get our app: trib.al/TBXgYpp
Find us on cable: trib.al/YDOpGyG
How to watch on TV or streaming: trib.al/Vu0Ikij